InChI=1S/C45H69N5O8S/c1- 13- 27(3) 38- 43(55) 50- 20- 14- 15- 35(50) 44(56) 58- 37(45(7,8) 9) 22- 26(2) 21- 36(51) 29(5) 40- 46- 32(25- 59- 40) 23- 28(4) 39(52) 47- 34(24- 31- 16- 18- 33(57- 12) 19- 17- 31) 42(54) 48(10) 30(6) 41(53) 49(38) 11/h16- 19,23,26- 27,29- 30,32,34- 38,51H,13- 15,20- 22,24- 25H2,1- 12H3,(H,47,52) /b28- 23+/t26- ,27- ,29- ,30- ,32- ,34- ,35- ,36- ,37- ,38- /m0/s1 |
KXUJXPZXILTXDA-CKIYSKEDSA-N |
[H] N1[C@@H] (Cc2ccc(OC) cc2) C(=O) N(C) [C@@H] (C) C(=O) N(C) [C@@H] ([C@@H] (C) CC) C(=O) N2CCC[C@H] 2C(=O) O[C@@H] (C[C@@H] (C) C[C@H] (O) [C@H] (C) C2=N[C@H] (CS2) \C=C(C) \C1=O) C(C) (C) C |
|
Lyngbya majuscula
(NCBI:txid158786)
|
See:
PubMed
|
Lyngbya bouillonii
(NCBI:txid207920)
|
of strain
PS372
See:
PubMed
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
7'''.1,4- anhydro(N- {3- [2- (3,7- dihydroxy- 5,8,8- trimethylnonan- 2- yl)- 4,5- dihydro- 1,3- thiazol- 4- yl]- 2- methylpropenoyl}- O- methyl- L- tyrosyl- N- methyl- L- alanyl- N- methyl- L- isoleucyl- L- proline)
|
(2S,3S,5S,7S,10S,16S,19S,22S,25E,27S)- 16- [(2S)- butan- 2- yl]- 7- tert- butyl- 3- hydroxy- 22- (4- methoxybenzyl)- 2,5,17,19,20,25- hexamethyl- 8- oxa- 29- thia- 14,17,20,23,30- pentaazatricyclo[25.2.1.010,14]triaconta- 1(30),25- diene- 9,15,18,21,24- pentone
|
IUPAC
|
apratoxin A
|
ChemIDplus
|
N- ((2E)- 3- ((4S)- 4,5- dihydro- 2- ((1S,2S,4S,6S)- 2,6- dihydroxy- 1,4,7,7- tetramethyloctyl)- 4- thiazolyl)- 2- methyl- 1- oxo- 2- propenyl)- O- methyl- L- tyrosyl- N- methyl- L- alanyl- N- methyl- L- isoleucyl- L- proline- (4- 1(6))- lactone
|
ChemIDplus
|
350791-64-9
|
CAS Registry Number
|
ChemIDplus
|
9181215
|
Beilstein Registry Number
|
Beilstein
|
9181215
|
Reaxys Registry Number
|
Reaxys
|
11389621
|
PubMed citation
|
Europe PMC
|
18461997
|
PubMed citation
|
Europe PMC
|
|